Glenmark Pharmaceuticals today launched 'Digihaler', the country's first digital dose inhaler (DDI), for asthma and chronic obstructive pulmonary disease (COPD) patients.
Glenmark Pharmaceuticals has rolled out an EMI scheme for cancer patients in order to help them continue the treatment and meet the high cost of medication
According to IMS, the Lotrisone cream market achieved annual sales of approximately $82.4 million Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U
Glenmark Pharmaceuticals share price gained as much as 4.5 per cent in the morning trade on Friday after the company informed stock exchanges that Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the
Glenmark Pharmaceuticals today reported 19.81 per cent increase in consolidated net profit to Rs 197.78 crore for the second quarter ended September 30, driven by good growth in India, US and Europe.
Glenmark Pharmaceuticals has entered into an agreement with Poland based Celon Pharma to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler in Europe used for treatment of lung diseases.
India's pharmaceutical industry is expected to see sales and profit growth accelerate in the second half of the year, thanks to a pickup in the pace of U.S. approvals for new drugs, offsetting any downturn in volatile emergin
Earlier, in an interim order, a division bench of the Delhi high Court had restrained Glenmark from making or selling its drug, used for treatment of Type-2 diabetes.
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for Voriconazole Tablets, used to treat fungal infections.
Cipla stocks will be in focus today as the the Indian generic drugmaker on Friday informed BSE that its UK arm, Cipla EU, has entered into definitive agreements to acquire two US-based companies InvaGen Pharmaceuticals Inc an
